Close
Nordic 9Nordic 9

Eli Lilly and Company (investor - Corporate Investor)

United Kingdom lilly.com
See something wrong or missing? Let us know
Offices:Indianapolis

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis

Average round investment:40.68M USD
Average number per year:4.2
Distribution: 2025 (6)2024 (4)2023 (5)2021 (2)
Portfolio companies: United Kingdom TrogenixUnited Kingdom AlchemabUnited Kingdom Laverock Therapeutics See the entire list
Mostly invests in: United Kingdom United Kingdom (10) Health services (17)
See the entire list

Showing 3 of 17 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Eli Lilly and Company mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Eli Lilly and Company

Name Criteria
United States White Star Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 4.2
  • Active last 12 months: Yes
Spain Kibo Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 4.1
  • Active last 12 months: Yes
Spain Asabys Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services
  • Similar business models: B2B
  • Common investees countries: France, Belgium
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
Poland Mati Staniszewski
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 4.0
  • Active last 12 months: Yes
Germany ECBF
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: Denmark, France, Belgium, Netherlands
  • Average number of deals per year: 4.8
  • Active last 12 months: Yes
Denmark Victor Riparbelli
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Denmark
  • Average number of deals per year: 3.7
  • Active last 12 months: Yes
United States Spark Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France, Netherlands
  • Average number of deals per year: 4.9
  • Active last 12 months: Yes
United Kingdom Wellington Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Denmark, France, Switzerland, Belgium, Netherlands
  • Average number of deals per year: 3.6
  • Active last 12 months: Yes
United Kingdom Cambridge Innovation Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 3.5
  • Active last 12 months: Yes
United States Goodwater Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Denmark, France
  • Average number of deals per year: 5.0
  • Active last 12 months: Yes
Top